Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-23

Clinical Trial Update: Effect of Addition of Mannitol to Bupivacaine on IANB Success and Post-endodontic Pain [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial assessing whether adding mannitol to bupivacaine improves inferior alveolar nerve block success and reduces post-endodontic pain in irreversible…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mannitol to bupivacaine

Snippet

Sponsor: Cairo University | Conditions: Irreversible Pulpitis | Phase 2, Phase 3 | Status: COMPLETED